Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|December 31, 2021
Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell CarcinomaKristian B Laursen, Qiuying Chen, Francesca Khani, et al.
Urology|June 16, 2019
Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder CancerKinnari R Patel, Benjamin L Taylor, Francesca Khani, et al.
European Urology Oncology|May 18, 2019
The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion BiopsyNeal Patel, Eliza Cricco-Lizza, Khushabhu Kasabwala, et al.
American Journal of Clinical Pathology|August 6, 2022
Recognition Awards in Pathology Specialty SocietiesSara E Wobker, Paula S Ginter, Carlos Parra-Herran, et al.
Cancer Treatment and Research Communications|September 26, 2020
Contemporary Results and Clinical Utility of Renal Mass Biopsies in the Setting of Ablative Therapy: A single center experienceLucy X Ma, Kiersten M Craig, Juan Miguel Mosquera, et al.
Urologic Oncology|February 10, 2021
Tumor size and genomic risk in localized prostate cancerChristopher Gaffney, Deli Liu, Victoria Cooley, et al.
The Journal of Urology|April 2, 2019
The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate CancerChristopher Gaffney, Ron Golan, Miguel D Cantu, et al.
European Urology Focus|July 11, 2021
Clipless Robotic-assisted Radical Prostatectomy and Impact on OutcomesSpyridon P Basourakos, Alec Zhu, Patrick J Lewicki, et al.
European Urology Oncology|September 8, 2019
Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysisShokhi Goel, Jonathan E Shoag, Michael D Gross, et al.
The Journal of Pathology|April 18, 2019
Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutationsFrancesca Khani, Sara E Wobker, Jessica L Hicks, et al.
Pageof 9